Internal medicine journal
-
Internal medicine journal · Jan 2023
Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum.
The goal of therapy in type 1 diabetes (T1D) is to achieve optimal glycaemic targets and reduce complications. Robust data representing glycaemic outcomes across the lifespan are lacking in Australasia. ⋯ Only a minority of children and adults achieve the recommended glycaemic goals despite access to specialist care in major diabetes centres. There is a need to identify factors that improve glycaemic outcomes.
-
Internal medicine journal · Jan 2023
Comment Observational StudyEffects of a prescribed, supervised exercise program on tumour disease progression in oncology patients undergoing anti-cancer therapy: A retrospective observational cohort study.
Exercise promotes numerous advantages in both health and disease, and is increasingly being acknowledged to improve overall survival in cancer patients. Preclinical studies indicate a direct effect on tumour behaviour, but human data on the effect of exercise on tumour progression are lacking. ⋯ Supervised exercise programmes have the potential to significantly improve outcomes in cancer patients due to an effect on tumour progression.
-
Internal medicine journal · Jan 2023
Symptom persistence and recovery among COVID-19 survivors during a limited outbreak in Canterbury, New Zealand: a prospective cohort study.
In Canterbury, near complete identification of coronavirus disease 2019 (COVID-19) cases during a limited outbreak provides unique insights into sequelae. ⋯ Persistent symptoms and longer recovery times were found in COVID-19 survivors, but not impaired generalised anxiety levels or HrQoL compared with COVID-19-uninfected participants.